SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-234618
Filing Date
2012-05-15
Accepted
2012-05-15 16:16:55
Documents
11
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d333469d10q.htm 10-Q 298306
2 EX-31.1 d333469dex311.htm EX-31.1 9403
3 EX-31.2 d333469dex312.htm EX-31.2 9384
4 EX-32.1 d333469dex321.htm EX-32.1 3902
5 EX-32.2 d333469dex322.htm EX-32.2 3887
  Complete submission text file 0001193125-12-234618.txt   1389505

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT cprx-20120331.xml EX-101.INS 137373
7 XBRL TAXONOMY EXTENSION SCHEMA cprx-20120331.xsd EX-101.SCH 11341
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cprx-20120331_cal.xml EX-101.CAL 23246
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cprx-20120331_def.xml EX-101.DEF 7464
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE cprx-20120331_lab.xml EX-101.LAB 96664
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cprx-20120331_pre.xml EX-101.PRE 68226
Mailing Address 355 ALHAMBRA CIRCLE SUITE 1500 CORAL GABLES FL 33134
Business Address 355 ALHAMBRA CIRCLE SUITE 1500 CORAL GABLES FL 33134 (305) 529-2522
CATALYST PHARMACEUTICAL PARTNERS, INC. (Filer) CIK: 0001369568 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33057 | Film No.: 12844916
SIC: 2834 Pharmaceutical Preparations